References
- von PawelJSchillerJHShepherdFATopotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancerJ Clin Oncol19991765866710080612
- YanaTNegoroSTakadaMPhase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJOG) studyInvest New Drugs20072525325817039404
- NodaKNishiwakiYKawaharaMIrinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancerN Engl J Med2002346859111784874
- YamaokaTHanadaMIchiiSCytotoxicity of amrubicin, a novel 9-aminoanthracycline, and its active metabolite amrubicinol on human tumor cellsJpn J Cancer Res199889106710739849587
- HanadaMMizunoSFukushimaAA new antitumor agent amrubicin induces cell growth inhibition by stabilizing topoisomerase II-DNA complexJpn J Cancer Res199889122912389914793
- MorisadaSYanagiYNoguchiTAntitumor activities of novel 9-aminoanthracycline (SM-5887) against mouse experimental tumors and human tumor xenograftsJpn J Cancer Res19898069762496061
- MorisadaSYanagiYKashiwazakiYToxicological aspects of a novel 9-aminoanthracycline, SM-5887Jpn J Cancer Res19898077822496062
- SuzukiTMinamideSIwasakiTCardiotoxicity of a new anthracycline derivative (SM-5887) following intravenous administration to rabbits: Comparative study with doxorubicinInvest New Drugs1997152192259387044
- OnodaSMasudaNSetoTPhase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancerJ Clin Oncol2006245448545317135647
- KairaKSunagaYTomizawaYA Phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancerLung Cancer200934513456
- JotteRMConklingPRReynoldsCA randomized Phase 2 trial of amrubicin (AMR) vs topotecan as second-line treatment in extensive-disease small cell lung cancer (SCLC) sensitive to platinum-based first-line chemotherapyJ Clin Oncol20082615S8040
- InoueASugawaraSYamazakiKRandomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402J Clin Oncol2008265401540618854562